Showing results (551-560 of 777) with videos related to

Sort By:
Pageof 78
Virchows Archiv : an International Journal of Pathology|September 13, 2023
Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
The Journal of Urology|September 8, 2022
Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active SurveillanceClaire M de la Calle, Mufaddal M Mamawala, Patricia Landis, et al.
The American Journal of Surgical Pathology|June 14, 2019
Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF StatusSara E Wobker, Andres Matoso, Christine A Pratilas, et al.
The American Journal of Pathology|October 15, 2019
RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular SubtypeUjjawal Manocha, Jordan Kardos, Sara Selitsky, et al.
The Journal of Urology|May 7, 2013
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillanceJeffrey J Tosoian, Eric JohnBull, Bruce J Trock, et al.
The American Journal of Surgical Pathology|September 25, 2013
GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladderCarla L Ellis, Alex G Chang, Ashley Cimino-Mathews, et al.
The Journal of Urology|November 21, 2017
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active SurveillanceOudai Hassan, Misop Han, Amy Zhou, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasiaTamara L Lotan, Berrak Gumuskaya, Hameed Rahimi, et al.
Archives of Pathology & Laboratory Medicine|January 13, 2024
Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial CarcinomaGuan-Nan Zhang, Barbara Susnik, Emma J Paulsen, et al.
Pageof 78